Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Epigenomes and Transcriptomes of human macrophages after ex vivo exposure to mevalonate

ABSTRACT: Epigenomes and Transcriptomes of human macrophages after ex vivo exposure to mevalonate

PROVIDER: PRJNA412081 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR6073220.fastq.gz	Fastqsanger.gz
	SRR6073230.fastq.gz	Fastqsanger.gz
	SRR6073221.fastq.gz	Fastqsanger.gz
	SRR6073231.fastq.gz	Fastqsanger.gz
	SRR6073222.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 12

Similar Datasets

Epigenomes and Transcriptomes of human macrophages after ex vivo exposure to mevalonate

Project description:Innate immune memory, also refered to as trained immunity (TRIM) is the phenomenon whereby innate immune cells such as monocytes or macrophages undergo functional reprogramming after exposure to microbial components. In this study we exposed monocytes from healthy donors to mevalonate ex vivo, and analyzed the effect of this exposure on gene expression and histone modification changes.

2018-01-08 | GSE104227 | GEO

Transcriptomes of human monocytes after ex vivo exposure to uric acid

Project description:Innate immune memory, also refered to as trained immunity (TRIM) is the phenomenon whereby innate immune cells such as monocytes or macrophages undergo functional reprogramming after exposure to microbial components. In this study we exposed monocytes from healthy donors to uric acid ex vivo, and analyzed the effect of this exposure on gene expression changes. After 'uric acid' or 'media only' treatments, monocytes were exposed to LPS for 4 hours to measure they response to this pyrogen.

2017-12-08 | GSE107821 | GEO

Transcriptomes of human monocytes after ex vivo exposure to uric acid

Project description:Transcriptomes of human monocytes after ex vivo exposure to uric acid

| PRJNA421491 | ENA

Mevalonate pathway inhibition affects bladder cancer metastasis

Project description:Metastasis is an important factor affecting the prognosis and survival of bladder cancer (BLCA) patients. Our previous study found that the mevalonate pathway is associated with the migratory ability of BLCA cells, but the exact mechanism is unclear. Here, we found that BLCA patients with mevalonate pathway activation had a poorer prognosis. Inhibition of the mevalonate pathway (FDPS knockdown, simvastatin or zoledronic acid) significantly reduced the migratory ability of BLCA cells. Therefore, we tested the changes of key genes after knocking down the key enzymes of the mevalonate pathway, FDPS and SQLE1, and the transcription factor YY1 in bladder cancer cells using RNA sequencing.

2024-09-08 | GSE252007 | GEO

Rat oocyte epigenomes

Project description:Rat oocyte epigenomes

| PRJNA769697 | ENA

Role of mevalonate pathway intermediates in anticancer effect of statins

Project description:Simvastatin has been widely used for treatment of hypercholesterolemia due to its ability to inhibit HMG-CoA reductase, the rate limiting enzyme of de novo cholesterol synthesis via mevalonate pathway. Its inhibitory action causes also depletion of pathway intermediates, farnesyl pyrophosphate (FPP) and geranyl-geranyl pyrophosphate (GGPP), which are inevitable for proper targeting of small GTPases (e.g. Ras proteins) to their site of action. We profiled by array the gene expression of MIA PaCa-2 cells treated with simvastatin, FPP, GGPP and their combinations. The inhibitory effect of statins on GFP-K-Ras protein trafficking were partially prevented by addition of the mevalonate pathway intermediates. We conclude that the anticancer effect of simvastatin is to a large extent mediated through isoprenoid intermediates of the mevalonate pathway.

2018-03-31 | E-MTAB-3263 | biostudies-arrayexpress

Transcriptomes of human monocytes exposed to oxLDL ex vivo

Project description:Transcriptomes of human monocytes exposed to oxLDL ex vivo

| PRJNA699753 | ENA

SMS TMT surfaceome comparison of ex vivo derived M1 macrophages treated with dexamethasone

Project description:Triplicate samples of donor matched ex vivo generated macrophage subtype M1 cells treated with and without dexamethasone compared against the M0 control analysed using TMT-based 11plex quantitative proteomics.

2023-09-04 | PXD032967 | Pride

SMS TMT surfaceome comparison of ex vivo derived M1 macrophages treated with dexamethasone

2023-09-04 | PXD032966 | Pride

SMS TMT surfaceome comparison of ex vivo derived M1 macrophages treated with dexamethasone

2023-09-04 | PXD032905 | Pride